The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis.

about

Effect of Narrow Spectrum Versus Selective Kinase Inhibitors on the Intestinal Proinflammatory Immune Response in Ulcerative Colitis Syk inhibitors in clinical development for hematological malignancies.Anti-Inflammatory Effects of Protein Kinase Inhibitor Pyrrol Derivate.

P2860

Q41826640-43422CEA-464B-4F84-AE21-920946A61AE5 Q42011012-DA60E5F1-E774-44BF-B5B9-8949C251CEF3 Q51182340-022E9405-F183-4842-A202-C982454001C6

P2860

The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis.

Item

http://www.wikidata.org/entity/Q53451864

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The Syk Inhibitor Fostamatinib ...... in a Rodent Model of Colitis.

@en

The Syk Inhibitor Fostamatinib ...... in a Rodent Model of Colitis.

@nl

type

Item

label

The Syk Inhibitor Fostamatinib ...... in a Rodent Model of Colitis.

@en

The Syk Inhibitor Fostamatinib ...... in a Rodent Model of Colitis.

@nl

prefLabel

The Syk Inhibitor Fostamatinib ...... in a Rodent Model of Colitis.

@en

The Syk Inhibitor Fostamatinib ...... in a Rodent Model of Colitis.

@nl

P1476

The Syk Inhibitor Fostamatinib ...... e in a Rodent Model of Colitis

@en

P2093

Bulent Yilmaz

http://www.w3.org/2001/XMLSchema#string

Guray Can

http://www.w3.org/2001/XMLSchema#string

Hasan Aksit

http://www.w3.org/2001/XMLSchema#string

Hatice Can

http://www.w3.org/2001/XMLSchema#string

Mevlut Kurt

http://www.w3.org/2001/XMLSchema#string

Selim Demirtas

http://www.w3.org/2001/XMLSchema#string

Suleyman Ayvaz

http://www.w3.org/2001/XMLSchema#string

Ugur Korkmaz

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory Bowel Disease

Structure and function of Syk protein-tyrosine kinase

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk.

Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis.

Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies.

Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content

Current and emerging biologics for ulcerative colitis.

Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.

Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases.

Targeting Syk as a treatment for allergic and autoimmune disorders.

P304

907-917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ECCO-JCC/JJV114

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Turan KARACA

P577

2015-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279300618

http://www.w3.org/2001/XMLSchema#string

P698

26116555

http://www.w3.org/2001/XMLSchema#string

The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis.

about

P2860

P2860

The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698